The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50
Abstract
We have previously reported methicillin-resistant Staphylococcus aureus clinical strains, Mu50 and Mu3, representing two categories of vancomycin resistance: Mu50 representing vancomycin-resistant S. aureus (VRSA) with MICs > or = 8 mg/L, and Mu3 representing hetero-VRSA with MICs < or = 4 mg/L using standard MIC determination methods. The mechanisms of vancomycin resistance in these strains were investigated. These strains did not carry the enterococcal vancomycin-resistance genes, vanA, vanB, or vanC1-3, as tested by PCR using specific primers. However, both strains produced three to five times the amount of penicillin-binding proteins (PBPs) 2 and 2' when compared with vancomycin-susceptible S. aureus control strains with or without methicillin resistance; the amounts of PBP2 produced in Mu3 and Mu50 were comparable to those in the vancomycin-resistant S. aureus mutant strains selected in vitro. Incorporation of 14C-labelled Nacetyl-glucosamine into the cell was three to 20 times increased in Mu50 and Mu3, and release of the radioactive cell wall material was increased in Mu3 (and also in Mu50, though to a lesser extent), compared with control strains. The amounts of intracellular murein monomer precursor in these strains were three to eight times greater than those found in control strains. Transmission electron microscopy showed a doubling in the cell wall thickness in Mu50 compared with the control strains. Mu3 did not show obvious cell wall thickening. These data indicate that activated synthesis and an increased rate of cell wall turnover are common features of Mu3 and Mu50 and may be the prerequisite for the expression of vancomycin resistance in S. aureus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Self-citationHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Self-citationNoble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584
Liu, F.-T., Zinnecker, M., Hamaoka, T., & Katz, D. H. (1979) · Biochemistry · doi:10.1021/bi00571a022 · Cited by 460
Characterization of glycopeptide-resistant enterococci from U.S. hospitals
Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M., & Tenover, F. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2311 · Cited by 395
Utsui, Y., & Yokota, T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.397 · Cited by 365
de Jonge, B. L., Chang, Y. S., Gage, D., & Tomasz, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49903-1 · Cited by 315
Hiramatsu, K. (1995) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1995.tb02239.x · Cited by 206
Camilli, A., Portnoy, A., & Youngman, P. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.7.3738-3744.1990 · Cited by 174
Distribution of mec regulator genes in methicillin-resistant Staphylococcus clinical strains
Suzuki, E., Kuwahara‐Arai, K., Richardson, J. F., & Hiramatsu, K. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1219 · Cited by 144
Dutka‐Malen, S., Leclercq, R., Coutant, V., Duval, J., & Courvalin, P. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.1875 · Cited by 142
Kuwahara‐Arai, K., Kondo, N., Hori, S., Tateda-Suzuki, E., & Hiramatsu, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2680 · Cited by 136
Moreira, B. M., Boyle‐Vavra, S., DeJonge, B. L. M., & Daum, R. S. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1788 · Cited by 131
Daum, R. S., Gupta, S., Sabbagh, R., & Milewski, W. M. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.5.1066 · Cited by 130
Gustafson, J. E., Strässle, A., Hächler, H., Kayser, F. H., & Berger‐Bächi, B. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.5.1460-1467.1994 · Cited by 111
DeJonge, B. L. M., & Tomasz, A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.342 · Cited by 98
Shlaes, D. M., Shlaes, J. H., Vincent, S., Etter, L., Fey, P. D., & Goering, R. V. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2432 · Cited by 90
Hiramatsu, K., Suzuki, E., Takayama, H., Katayama, Y., & Yokota, T. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.4.600 · Cited by 70
A highly vancomycin-resistant laboratory mutant ofStaphylococcus aureus
Sieradzki, K., & Tomasz, A. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08424.x · Cited by 62
Teicoplanin Selects for Staphylococcus aureus That Is Resistant to Vancomycin
Shlaes, D. M., & Shlaes, J. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.1071 · Cited by 43
Milewski, W. M., Boyle‐Vavra, S., Moreira, B. M., Ebert, C. C., & Daum, R. S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.166 · Cited by 42
Cited by
Mechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Katayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
Iwase, T., Uehara, Y., Shinji, H., Tajima, A., Seo, H., Takada, K., Agata, T., & Mizunoe, Y. (2010) · Nature · doi:10.1038/nature09074 · Cited by 991
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Metadata
- Authors
- Hanaki, H.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-08-01
- Volume
- 42
- Issue
- 2
- Pages
- 199-209
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2124205716
- Cited by
- 366
- References
- 23
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.